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Two patients with granulomatous lung lesions thought to be related to Crohn’s disease (CD) are reported.
Patient 1 was a 43-year-old man who was diagnosed with CD at age 11 years. He developed a fever in the
38 C, and a chest X-ray and CT scan showed inﬁltrates with air bronchograms in the right upper lobe and
left lingular segment. Transbronchial lung biopsy (TBLB) revealed granulomatous lesions. Patient 2 was a
76-year-old womanwho was diagnosed with CD at age 44 years. Chest CT showed inﬁltrates and nodular
shadows in both lung ﬁelds. Video-assisted thoracoscopic surgery (VATS) in June 2012 revealed granu-
lomatous lesions. Tuberculosis, fungal infections, drug-induced lung disorder, and sarcoidosis were ruled
out as a cause of the granulomatous lesions in both patients. The aetiology was thought to be CD.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Crohn’s disease (CD) is a granulomatous inﬂammatory disease
of unknown aetiology, but thought to involve abnormal immune
function, with a predilection to develop in the small and large in-
testines [1,2]. Granulomatous lung lesions in CD have not previ-
ously been reported in Japan, and only 3 cases have been reported
overseas [3]. Two rare cases of CD-related granulomatous lung le-
sions are reported, and the relevant literature is discussed.2. Case reports
2.1. Patient 1
Patient 1 was a 43-year-old manwho was diagnosed with CD in
1979 (age 11 years). He had been followed as an outpatient by the
Department of Gastroenterology at our hospital. He underwent an
ileocoecal resection in 1981 (age 13 years), partial small bowely Medicine, Fukuoka Univer-
-shi, Fukuoka-ken 814-8502,
a).
Ltd. Open access under CC BY-NC-NDresection in 1987 (age 19 years), and transverse colon strictur-
eplasty in 1999 (age 31 years). Parenteral nutrition (elemental diet:
Elental, Racol) was then started. Mesalazine (5-ASA) was started in
2006, and inﬂiximab (an anti-TNF-a antibody drug) was started in
2007 (age 39 years). However, he continued to have severe active
CD, and adalimumab (another anti-TNF-a antibody drug) was
started in March 2011 (age 42 years). The patient’s gastrointestinal
symptoms were controlled, but he developed a dry cough in mid-
November 2011 (age 43 years), followed by a fever (38 C) in
early December 2011, and he was evaluated by our department.
A chest X-ray and CT showed bilateral inﬁltrates with air bron-
chograms (Fig. 1). The patient was diagnosed with community-
acquired pneumonia (WBC 4300/mL, CRP 0.07 mg/dL), and antibi-
otic therapy with ceftriaxone (CTRX) was prescribed. However,
since the dry cough did not improve, the patient was admitted to
our department in mid-December 2011 for further evaluation and
treatment. Bronchoscopy was performed, and transbronchial lung
biopsy (TBLB) of the right upper lobe revealed a non-caseating
granuloma with multi-nucleated giant cells (Fig. 2).
As testing for the aetiology of the granulomatous lesions, a
QuantiFERON-TB test was negative, a tuberculin reaction was
negative, and acid-fast staining of the bronchoscopy specimens
(bronchial lavage ﬂuid, TBLB) was negative. Thus, tuberculosis was
unlikely. Grocott staining, b-D glucan, and cryptococcal antigen license.
Fig. 1. Chest X-ray (left) and CT (right) taken in December 2011 show inﬁltrative
shadows in the bilateral upper lobes.
Fig. 3. Chest X-ray (left) and CT (right) taken in August 2012. The inﬁltrative shadow
noted in Fig. 1 has disappeared spontaneously.
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was also unlikely. Aggressive therapy was not considered neces-
sary, so the patient was followed as an outpatient. On a chest X-ray
taken in July 2012, and on chest CT in August 2012, the inﬁltrate
mainly in the right upper lobe had spontaneously disappeared
(Fig. 3).
2.2. Patient 2
Patient 2 was a 76-year-old woman who was diagnosed with
small intestinal CD in 1980 (age 44 years). She has been followed as
an outpatient by the Department of Gastroenterology at our hos-
pital. Salazosulfapyridine (5-ASA) was started in 1985 (age 49
years). She underwent a small bowel strictureplasty in 1992 (age 56
years), ileocoecal resection in 2003 (age 67 years), and then
parenteral nutrition (Elental) was started.
The patient’s gastrointestinal symptoms were well controlled,
but she began to lose weight in September 2011 (10 kg weight loss/
6 months). A CT scan in December 2011 showed thickened bron-
chiolar walls with multiple nodular shadows in peripheral bronchi
of both lung ﬁelds, and bronchoscopy was performed in February
2012. The bronchoalveolar lavage (BAL) ﬂuid showed predominant
lymphocytosis (57%) and a CD4/CD8 ratio of 0.94. TBLB revealed no
signiﬁcant ﬁndings.
Chest X-ray and CT in May 2012 showed new inﬁltrates in the
right lower and left upper lobes (Fig. 4). In June 2012, Video-
assisted thoracoscopic surgery (VATS) of the lingula was per-
formed, and histopathology showed an epithelioid cell granuloma
with giant cells (Fig. 5). Since acid-fast cultures of the bronchialFig. 2. Photomicrogram of transbronchial lung biopsy reveals non-caseating granu-
loma with multi-nucleated giant cells and lymphocytic inﬁltrate (haematoxylin-
eosin,  140).lavage ﬂuid and lung biopsy tissue were negative, a mycobacterial
infection was unlikely. Grocott staining, b-D glucan, and crypto-
coccal antigen testing were negative, so a fungal infection was also
unlikely. Serum ACE was not elevated, the tuberculin reaction was
negative, and the pulmonary hilar lymph nodes were not enlarged;
thus, sarcoidosis was also ruled out. Drug treatment had not been
switched during outpatient follow-up, so drug-induced pneumonia
was also unlikely.
These ﬁndings were consistent with CD-related pulmonary le-
sions based on a diagnosis by exclusion and the histopathology. The
patient developed dyspnoea on exertion, and treatment with
tapering doses of prednisolone (PSL) starting at a dose of 40mg/day
was begun in July 2012. The exertional dyspnoea and imaging
ﬁndings improved rapidly (Fig. 6).
3. Discussion
Crohn’s disease (CD) was originally called regional ileitis and
was ﬁrst reported by Burrill B. Crohn MD at Mount Sinai Hospital
(United States) in 1932 [4]. CD is characterized by chronic inﬂam-
matory granulomatous lesions of unknown aetiology that are
associated with ulcerations and ﬁbrosis. CD usually presents in
younger patients with oedema and ulcerations in the small and
large intestines, and intestinal strictures and ﬁstulas often develop.
CD most commonly affects the terminal ileum, but any site in the
gastrointestinal tract may be involved [5]. Extra-intestinal com-
plications of CD include joint complications (ankylosing spondy-
litis, sacroiliitis, peripheral arthritis), skin complications (erythema
nodosum, pyoderma gangrenosum), ocular complications (epis-
cleritis, scleritis, uveitis), hepatobiliary complications (primary
sclerosing cholangitis), and pulmonary complications (organizing
pneumonia) [6].
When granulomatous lesions develop in CD patients, granulo-
matous infections such as mycobacterial or fungal infections, drug-
induced pneumonia, and sarcoidosis must be included in the dif-
ferential diagnosis. Granulomas in CD are sarcoid-like granulomas,Fig. 4. Chest X-ray (left) and CT (right) taken on admission May 2012 reveals inﬁl-
trative and small nodular shadow in the right lower and left upper lobes.
Fig. 5. Photomicrograph of biopsied lung tissue of case 2 reveals epithelioid cell
granuloma with multi-nucleated giant cells and lymphocytic inﬁltrate (haematoxylin-
eosin,  140).
Fig. 6. Chest X-ray and CT of August 2012. The inﬁltrative shadow of the right lower
and left upper lobes noted in Fig. 4 have improved.
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particularly important. A diagnosis of sarcoidosis requires 2 or
more of the following 6 ﬁndings indicating a systemic reaction:
bilateral pulmonary hilar lymphadenopathy, elevated serum ACE
levels, a negative tuberculin reaction, marked uptake on gallium67
citrate scintigraphy, lymphocytosis or an increased CD4/CD8 ratio
in BAL ﬂuid, and serum hypercalcaemia. Evaluation of these 6 items
is important to exclude a diagnosis of sarcoidosis [7,8].
In patient 1 at the time of hospital admission, a QuantiFERON-TB
blood assay was negative, acid-fast smear cultures of the bronchial
lavage ﬂuidwere negative, and acid-fast staining of TBLB specimens
was negative. Thus, tuberculosis was unlikely. Grocott staining, b-D
glucan, and cryptococcal antigen testing of the TBLB specimens
were negative, so a fungal infectionwas also unlikely. The only item
meeting the diagnostic criteria for sarcoidosis was a negative tu-
berculin reaction, but because the QuantiFERON-TB test was also
negative, this was thought to be of weak diagnostic signiﬁcance,
and sarcoidosis was ruled out. In addition, drug treatment had not
been switched during follow-up, so drug-induced pneumonia was
also unlikely. Based on a diagnosis of exclusion and the histopa-
thology, the ﬁndings were consistent with CD-related pulmonary
lesions.In patient 2, the histopathologic examination revealed an
epithelioid cell granuloma, multi-nucleated giant cells, and lym-
phocytic inﬁltration (Fig. 5). Acid-fast cultures of the bronchial
lavage ﬂuid and lung biopsy tissue were negative, so mycobacterial
infection was unlikely. Sarcoidosis was also ruled out based on lack
of elevation of serum ACE (15.5 IU/L) and a positive tuberculin re-
action. Drug-induced lung disorder was also unlikely because the
drug regimen had not been changed during outpatient treatment.
Three cases of granulomatous lung lesions in CD have been re-
ported outside of Japan (a 13-year-old girl, a 14-year-old girl, and a
17-year-old boy). However, such cases have not been previously
reported in Japan, so the present patients represent two rare cases.
All 3 patients reported outside of Japan were young, had severe
symptoms, and were being treated with inﬂiximab (anti-TNF-a
antibody drug). Regarding the present two cases in Japan, patient 1
(43-year-old man) was diagnosed with CD at age 11 years, and
because of active gastrointestinal symptoms, inﬂiximab (anti-TNF-
a antibody drug) was started. Patient 2 (76-year-old woman) was
diagnosed with CD at age 44 years, and she had a relatively satis-
factory clinical course on nutritional therapy alone. If we consider
the present 2 patients and the 3 patients reported from outside of
Japan, 4 of these 5 patients developed CD at a young age and had
highly active gastrointestinal symptoms [9]. Therefore, when lung
lesions are seen in patients who developed CD during their youth
and have highly active gastrointestinal symptoms, CD-related
granulomatous lung lesions must be considered.Conﬂict of interest
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